PFG Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$348K Sell
2,755
-1,044
-27% -$138K 0.02% 628
2026
Q1
$529K Buy
3,799
+182
+5% +$25.5K 0.03% 527
2025
Q4
$444K Sell
3,617
-2,647
-42% -$322K 0.02% 555
2025
Q3
$695K Buy
6,264
+420
+7% +$47.7K 0.03% 471
2025
Q2
$648K Buy
5,844
+1,899
+48% +$202K 0.03% 372
2025
Q1
$442K Sell
3,945
-64
-2% -$6.6K 0.02% 504
2024
Q4
$370K Sell
4,009
-52
-1% -$4.68K 0.02% 536
2024
Q3
$340K Sell
4,061
-89
-2% -$6.79K 0.02% 557
2024
Q2
$285K Buy
4,150
+1,137
+38% +$75.9K 0.02% 570
2024
Q1
$221K Sell
3,013
-260
-8% -$20K 0.02% 604
2023
Q4
$265K Sell
3,273
-88
-3% -$6.85K 0.02% 518
2023
Q3
$252K Buy
3,361
+652
+24% +$50.1K 0.02% 509
2023
Q2
$209K Buy
2,709
+13
+0.5% +$1.04K 0.02% 636
2023
Q1
$224K Buy
2,696
+93
+4% +$7.7K 0.02% 576
2022
Q4
$223K Buy
+2,603
New +$206K 0.02% 511
2020
Q3
Sell
-6,540
Closed -$499K 361
2020
Q2
$499K Buy
6,540
+175
+3% +$13.4K 0.11% 199
2020
Q1
$517K Sell
6,365
-77
-1% -$5.32K 0.14% 174
2019
Q4
$424K Buy
6,442
+130
+2% +$8.47K 0.1% 206
2019
Q3
$391K Sell
6,312
-75
-1% -$4.9K 0.11% 214
2019
Q2
$427K Sell
6,387
-200
-3% -$13.2K 0.12% 209
2019
Q1
$428K Sell
6,587
-564
-8% -$37.5K 0.13% 194
2018
Q4
$468K Buy
+7,151
New +$500K 0.15% 180

Other funds holding GILD

PFG Advisors's GILD Position: Q2 2026 in Review

PFG Advisors reduced its Gilead Sciences (GILD) stake by 27% in Q2 2026, selling an estimated $138K and leaving 2,755 shares worth $348K. The position accounts for 0.02% of the portfolio, ranked #628.

PFG Advisors first reported a position in GILD in Q4 2018 and has held it in 22 quarters since. The position peaked at $695K in Q3 2025. 850 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • PFG Advisors held 2,755 shares of Gilead Sciences worth $348K as of Q2 2026.
  • PFG Advisors sold 1,044 Gilead Sciences shares in Q2 2026, an estimated $138K.
  • Gilead Sciences made up 0.02% of PFG Advisors's portfolio in Q2 2026, its #628 holding.
  • PFG Advisors first reported a position in Gilead Sciences in Q4 2018 and has held it in 22 quarters since.
  • PFG Advisors's Gilead Sciences position peaked at $695K in Q3 2025.
  • 850 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on PFG Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.